Advertisement

Topics

Jiangbo Pharmaceuticals Enterprises, Inc. Company Profile

03:52 EDT 24th October 2017 | BioPortfolio

Jiangbo Pharmaceuticals, Inc. is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its operations are located in Eastern China in an Economic Development Zone in Laiyang City, Shandong province. Jiangbo is a major pharmaceutical company in China producing both western and Chinese herbal-based medical drugs in tablet, capsule, granule, syrup and electuary (sticky syrup) form. http://www.jiangbopharma.com


News Articles [533 Associated News Articles listed on BioPortfolio]

Piramal Enterprises net jumps by 31% to Rs. 302 cr in Q1

Piramal Enterprises, a well diversified company engaged in pharmaceuticals, finance and healthcare insights & analytics, has posted strong financial performance during the first quarter ended June 201...

Marathon Enterprises Inc. Recalls Hot Dog Products Due to Possible Extranous Material Contamination

Marathon Enterprises Inc., a Bronx, N.Y. establishment, is recalling approximately 7,196,084 pounds of hot dog products that may be contaminated with extraneous materials, specifically bone fragments.

TPI Enterprises buys Vistin opiates assets and confirms Portugal plant plan

TPI Enterprises has bought Vistin Pharma ASA’s opiates and tabletting division for A$25.4m ($201.m) in a deal designed to expand the firm beyond its narcotic raw materials business.

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology.

DePuy Synthes, Medical Enterprises enter co-marketing agreement

Johnson & Johnson subsidiary DePuy Synthes agreed to exclusively co-market Medical Enterprises Distribution's ME1000 surgical -More- 

Marathon Enterprises Inc. Retira Productos De Salchicha “Hot Dog” Debido A Posible Contaminación Con Material Extraño

Marathon Enterprises Inc., un establecimiento localizado en Bronx, N.Y. está retirando del mercado aproximadamente 7,196,084 libras de productos de salchicha (“hot dog”) que podrían esta...

AltMed Enterprises Opens First Arizona Dispensary

Coolidge, Arizona (PRWEB) August 31, 2017 AltMed Enterprises has opened its inaugural MüV by AltMed dispensary in Phoenix. Th...

Demakes Enterprises, Inc. Retira Productos De Salchicha De Pollo Debido A Un Error De Rotulacion Y Alérgeno No Declarado

Demakes Enterprises, Inc., un establecimiento localizado en Lynn, Mass., está retirando aproximadamente 32,228 libras de salchicha de pollo completamente cocido debido a un error de rotulación y al...

PubMed Articles [148 Associated PubMed Articles listed on BioPortfolio]

The shadow price of CO2 emissions in China's iron and steel industry.

As China becomes the world's largest energy consumer and CO2 emitter, there has been a rapidly emerging literature on estimating China's abatement cost for CO2 using a distance function approach. Howe...

Influences of reverse outsourcing on green technological progress from the perspective of a global supply chain.

As a newly appeared trade mode in recent years, reverse outsourcing has made a great impact on traditional trade modes. This paper researched the influences of reverse outsourcing on green technologic...

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Clinical Trials [205 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

What After the First Propess

The aim of this study is to compare three different regimens for continuation of induction of labor after no spontaneous or artificial rupture of membranes could be achieved after first 24...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Companies [1659 Associated Companies listed on BioPortfolio]

Jiangbo Pharmaceuticals Enterprises, Inc.

Jiangbo Pharmaceuticals, Inc. is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its opera...

Genesis Pharmaceuticals Enterprises, Inc.

Jiangbo Pharmaceuticals, Inc. is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its opera...

Jiangbo Pharmaceuticals, Inc.

Jiangbo Pharmaceuticals is engaged in the research, development, production, marketing and sales of pharmaceutical products in China. The Company's operations are located in Eastern China in an Ec...

Botanical Enterprises, Inc

Botanical Enterprises, Inc. (BEI) has been active in the field of botanical medicine since 1992 and was formally incorporated in Delaware in 1997. It is structured as a privately held "virtual" equity...

Hotze Enterprises

Hotze Enterprises, which includes Hotze Health & Wellness Center, Physician’s Preference and Hotze Pharmacy, is leading the revolution in wellness care by transforming the wa...

More Information about "Jiangbo Pharmaceuticals Enterprises, Inc." on BioPortfolio

We have published hundreds of Jiangbo Pharmaceuticals Enterprises, Inc. news stories on BioPortfolio along with dozens of Jiangbo Pharmaceuticals Enterprises, Inc. Clinical Trials and PubMed Articles about Jiangbo Pharmaceuticals Enterprises, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Jiangbo Pharmaceuticals Enterprises, Inc. Companies in our database. You can also find out about relevant Jiangbo Pharmaceuticals Enterprises, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record